A novel mutation in the coagulation factor 12 gene in subjects with hereditary angioedema and normal C1-inhibitor

Clinical Immunology

Volumn 141, Issue 1, 2011, Pages 31-35

  Bork, Konrad ^a   Wulff, Karin ^b   Meinke, Peter ^b   Wagner, Nicola ^c   Hardt, Jochen ^a   Witzke, Günther ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c Dept of Dermatology   (Germany)

Author keywords

Angioedema; Coagulation factor XII; Factor 12 gene mutation; Hereditary angioedema type III; Hereditary angioedema with normal C1 inhibitor

Indexed keywords

BLOOD CLOTTING FACTOR 12; COMPLEMENT COMPONENT C1S INHIBITOR;

ABDOMINAL PAIN; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; GENE LOSS; GENE MUTATION; HUMAN; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SKIN SWELLING; TURKEY (REPUBLIC);

ADULT; ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1 INHIBITOR PROTEIN; DNA MUTATIONAL ANALYSIS; EXONS; FACTOR XII; FACTOR XII DEFICIENCY; FEMALE; HUMANS; INTRONS; MALE; MUTATION; MUTATION, MISSENSE; PEDIGREE; SEQUENCE DELETION; TURKEY;

EID: 80053130267     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2011.07.002     Document Type: Article

References (23)

1. Quincke H. Über akutes umschriebenes Hautödem. Monatsh. Prakt. Dermatol. 1882, 1:129-131.
2. Osler W. Hereditary angioneurotic edema. Am. J. Med. Sci. 1888, 95:362-367.
3. Stoppa-Lyonnet D., Tosi M., Laurent J., Sobel A., Lagrue G., Meo T. Altered C1 inhibitor genes in type I hereditary angioedema. N. Engl. J. Med. 1987, 317:1-6.
4. Donaldson V.H., Evans R.R. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C1-esterase. Am. J. Med. 1963, 35:37-44.
5. Bissler J.J., Aulak K.S., Donaldson V.H., Rosen F.S., Cicardi M., Harrison R.A., Davis A.E. Molecular defects in hereditary angioneurotic edema. Proc. Assoc. Am. Physicians 1997, 109:164-173.
6. Zuraw B.L., Herschbach J. Detection of C1 inhibitor mutations in patients with hereditary angioedema. J. Allergy Clin. Immunol. 2000, 105:541-546.
7. Bork K., Barnstedt S.E., Koch P., Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000, 356:213-217.
8. Dewald G., Bork K. Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem. Biophys. Res. Commun. 2006, 343:1286-1289.
9. Cichon S., Martin L., Hennies H.C., Muller F., Van Driessche K., Karpushova A., Stevens W., Colombo R., Renne T., Drouet C., et al. Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am. J. Hum. Genet. 2006, 79:1098-1104.
10. Bouillet L., Ponard D., Rousset H., Cichon S., Drouet C. A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene. Br. J. Dermatol. 2007, 156:1063-1065.
11. Fiz Matias J., Ferrer Ceron S.M., Garcia Perez C., Marcos Vidal J.M. Analgesia obstetrica en un caso de edema angioneurotico hereditario tipo III. Rev. Esp. Anestesiol. Reanim. 2007, 54:253-254.
12. Martin L., Raison-Peyron N., Nothen M.M., Cichon S., Drouet C. Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene. J. Allergy Clin. Immunol. 2007, 120:975-977.
13. Prieto A., Tornero P., Rubio M., Fernandez-Cruz E., Rodriguez-Sainz C. Missense mutation Thr309Lys in the coagulation factor XII gene in a Spanish family with hereditary angioedema type III. Allergy 2009, 64:284-286.
14. Duan Q.L., Binkley K., Rouleau G.A. Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema. J. Allergy Clin. Immunol. 2009, 123:906-910.
15. Nagy N., Greaves M.W., Tanaka A., McGrath J.A., Grattan C.E. Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema. J. Dermatol. Sci. 2009, 56:62-64.
16. Hentges F., Hilger C., Kohnen M., Gilson G. Angioedema and estrogen-dependent angioedema with activation of the contact system. J. Allergy Clin. Immunol. 2009, 123:262-264.
17. Bork K., Wulff K., Hardt J., Witzke G., Staubach P. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. J. Allergy Clin. Immunol. 2009, 124:129-134.
18. Picone O., Donnadieu A.C., Brivet F.G., Boyer-Neumann C., Fremeaux-Bacchi V., Frydman R. Obstetrical complications and outcome in two families with hereditary angioedema due to mutation in the F12 gene. Obstet. Gynecol. Int. 2010, (Article ID 957507).
19. Vitrat-Hincky V., Gompel A., Dumestre-Perard C., Boccon-Gibod I., Drouet C., Cesbron J.Y., Lunardi J., Massot C., Bouillet L. Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy 2010, 65:1331-1336.
20. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988, 16:1215.
21. Gösswein T., Kocot A., Emmert G., Kreuz W., Martinez-Saguer I., Aygoren-Pursun E., Rusicke E., Bork K., Oldenburg J., Muller C.R. Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema. Cytogenet. Genome Res. 2008, 121:181-188.
22. Bork K., Kleist R., Hardt J., Witzke G. Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factor XII gene mutation Thr309Lys. Blood Coagul. Fibrinolysis 2009, 20:325-332.
23. Maas C., Govers-Riemslag J.W., Bouma B., Schiks B., Hazenberg B.P., Lokhorst H.M., Hammarstrom P., ten Cate H., de Groot P.G., Bouma B.N., et al. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J. Clin. Invest. 2008, 118:3208-3218.